Articles by Steve Davies

The debate over fats in the American diet has entered a critical phase for members of the Dietary Guidelines Advisory Committee, who barely have two months to finish their draft report and send it to Health and Human Services Secretary Alex Azar and Agriculture Secretary Sonny Perdue, who make the final decisions on what’s in and what’s out.

Two oil refiners have asked a federal appeals court to reconsider its decision restricting EPA’s ability to grant waivers to the Renewable Fuel Standard.

Farm groups have been nervously watching the high-stakes talks on a massive economic stimulus package between congressional leaders and Treasury Secretary Steven Mnuchin.

USDA shut down an office complex in Kansas City, Mo., due to a potential COVID-19 infection contracted during a Farm Service Agency conference held there from March 10 to March 13.

Producers who need to talk with someone at their county office now will have to make an appointment, as COVID-19 cases continue to increase nationwide.

The Food and Drug Administration is suspending routine surveillance inspections of U.S. facilities, citing concern for its staff and state contractors who conduct the plant checks.

EPA’s new method for determining how to evaluate the effects of pesticides on endangered species has been greeted with praise from the agricultural industry for offering a clear path forward for future evaluations, but sharp criticism from environmentalists for narrowing the universe of interagency reviews.

The USDA GIPSA proposal billed as bringing “clarity” to regulations enforcing the Packers and Stockyards Act is receiving opposition from some prominent government officials, including a commissioner of the Federal Trade Commission and eight state attorneys general.

Producers who are part of a corn class-action lawsuit that resulted in a $1.51 billion settlement with Syngenta will start receiving partial payments this month.

A draft settlement of lawsuits alleging a connection between Roundup exposure and cancer has been agreed to by Bayer and lawyers representing “tens of thousands” of plaintiffs, The Wall Street Journal reported Friday, citing “people familiar with the matter.”